NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/22/2025
Back to search
Official data from USPTO
DP DIAPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/12/2025
Trademark type
Combined
Nice classes
35
Filing date
05/28/2015
Registration date
02/09/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/22/2025
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/11/2015
First use in commerce
05/11/2015
Drawing code
5
Owner type
03
Owner location
West Chester, OH
Examiner
RITTNER, HANNO
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "dp" and the terminology "diapharma" in stylized writing.
Holders and representatives
Holders
DiaPharma Group, Inc.
Representatives
Francis J. Duffin Wiggin and Dana LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Distributorship services in the field of in vitro diagnostic and research products
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/22/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/22/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/22/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
02/25/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/09/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/14/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/14/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/14/2021
ES8R
TEAS SECTION 8 RECEIVED
02/10/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/09/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/24/2015
PUBO
PUBLISHED FOR OPPOSITION
11/24/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/04/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/19/2015
ALIE
ASSIGNED TO LIE
10/19/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2015
DOCK
ASSIGNED TO EXAMINER
09/09/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/04/2015
NWAP
NEW APPLICATION ENTERED
06/01/2015
Continuous trademark protection
Get notified about every new filing that threatens DP DIAPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.